medigraphic.com

2013, Number 5

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2013; 51 (5)

Female breast symptoms in patients attended in the family medicine practice

González-Pérez B, Salas-Flores R, Sosa-López ML, Barrientos-Guerrero CE, Hernández-Aguilar CM, Gómez-Contreras DE, Sánchez-Garza JA

Language: English
References: 23
Page: 558-561
PDF size: 52.97 Kb.


ABSTRACT

Background: there are few studies on breast symptoms (BS) in patients attended at primary care units in Mexico. The aim was to determine the frequency and types of BS overall and by age-group and establish which BS were related to diagnosis of breast cancer.
Methods: data from all female patients with breast disease related diagnosis, attended from 2006 to 2010, at the Family Medicine Unit 38, were collected. The frequencies of BS were determined by four age-groups (‹ 19, 20-49, 50-69, ›> 70 years) and likelihood ratios for breast cancer for each breast related symptom patient, with a 95 % confi dence interval (CI).
Results: the most frequent BS in the study population were lump/mass (71.7 %) and breast pain (67.7 %) of all breast complaints, and they were more noted in women age group of 20-49 years. Overall, 120 women had breast cancer diagnosed with a median age of 53.51 + 12.7 years. Breast lump/mass had positive likelihood ratios for breast cancer 4.53 (95 % CI = 2.51-8.17) and breast pain had increased negative LR = 1.08 (95 % CI = 1.05-1.11).
Conclusions: breast lump/mass was the predominant presenting complaint among females with breast symptoms in our primary care unit, and it was associated with elevated positive likelihood of breast cancer.


REFERENCES

  1. Morrow M. The evaluation of common breast problems. Am Fam Physician. 2000;61(8):2371-8, 2385.

  2. Malvezzi M, Bosetti C, Chatenoud L, Rodríguez T, Levi F, Negri E, et al. Trends in cancer mortality in Mexico, 1970-1999. Ann Oncol. 2004;15(11):1712-8.

  3. Wall KM, Núñez-Rocha G, Salinas-Martínez AM, Sánchez-Peña SR. Determinants of the use of breast cancer screening among women workers in urban Mexico. Prev Chronic Dis. 2008;5(2):A50.

  4. Rodríguez-Cuevas S, Guisa-Hohenstein F, Labastida- Almendaro S. First breast cancer mammography screening program in Mexico: initial results 2005- 2006. Breast J. 2009;15(6):623-31.

  5. Romero-Figueroa MS, Santillán-Arreygue L, Olvera- Hernández PC, Morales-Sánchez MA, Ramírez-Mendiola VL. Frecuencia de factores de riesgo de cáncer de mama. Ginecol Obstet Mex. 2008;76(11):667-72.

  6. Knaul FM, Nigenda G, Lozano R, Arreola-Ornelas H, Langer A, Frenk J. Breast cancer in Mexico: a pressing priority. Reprod Health Matters. 2008;16(32): 113-23.

  7. Bish A, Ramirez A, Burgess C, Hunter M. Understanding why women delay in seeking help for breast cancer symptoms. J Psychosom Res. 2005;58(4): 321-6.

  8. Gorin SS, Heck JE, Cheng B, Smith SJ. Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med. 2006;166(29):2244-52.

  9. Gullatte MM, Phillips JM, Gibson LM. Factors associated with delays in screening of self-detected breast changes in African-American women. J Natl Black Nurses Assoc. 2006;17(1):45-50.

  10. Irwig L, Macaskill P, Houssami N. Evidence relevant to the investigation of breast symptoms: the triple test. Breast. 2002;11(3):215-20.

  11. Organización Mundial de la Salud. Clasifi cación Internacional de Enfermedades (CIE 10). Décima revisión. Ginebra, Suiza: Organización Mundial de la Salud; 1995.

  12. Eberl MM, Phillips RL Jr, Lamberts H, Okkes I, Mahoney MC. Characterizing breast symptoms in family practice. Ann Fam Med. 2008;6(6):528-33.

  13. Morrow M, Wong S, Venta L. The evaluation of breast masses in women younger than forty years of age. Surgery. 1998;124(4):634-40.

  14. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med. 1998;338(16):1089-96.

  15. Morrow M. Management of common breast disorders: breast pain. In. Breast diseases. 2nd ed. Philadelphia: Lippincott; 1991. p. 63-71.

  16. Romero-Jaime R, Martínez-Becerra D, Mainero- Ratchelous F. Mastalgia y nódulo mamario. Rev Cuestion Social. 2005;58:20-38.

  17. Amaro-Heredia M, Bautista-Samperio L, Arrieta-Pérez RT. Correlación de factores de riesgo y hallazgos clínicos para cáncer mamario en pre y posmenopáusicas. Rev Fac Med UNAM. 2007;50(3):110-4.

  18. Prevención y diagnóstico oportuno de cáncer de mama en el primer nivel de atención. México: Secretaría de Salud; 2008.

  19. Diagnóstico y tratamiento de la patología mamaria benigna en primer y segundo nivel de atención. México: Secretaría de Salud; 2009.

  20. Newton P, Hannay DR, Laver R. The presentation and management of female breast symptoms in general practice in Sheffi eld. Family Practice. 1999;16: 360-5.

  21. The presentation and management of breast symptoms in general practice in South Wales. The BRIDGE Study Group. Br J Gen Pract. 1999;49(447):811-2.

  22. Donnelly J. Breast lump detection: who is more accurate, patients or their GPs?. Int J Clin Pract. 2010; 64(4):439-41.

  23. Bright K, Barghash M, Donach M, de la Barrera MG, Shneider R, Formenti SC. The role of health system factors in delaying fi nal diagnosis and treatment of breast cancer in Mexico City, Mexico. Breast. 2011; 20(Suppl 2):S54-9.




2020     |     www.medigraphic.com